SCHEMBL31723127

SCHEMBL31723127

O=C(O)c1c(-c2cccs2)oc2ccc(Br)cc2c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.52
MEN1 O00255 5/20 0.52
KDM4E B2RXH2 5/20 0.52
MAPT P10636 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
HTT P42858 3/20 0.52
USP2 O75604 2/20 0.52
GAA P10253 2/20 0.52
POLB P06746 1/20 0.52
ALDH1A1 P00352 4/20 0.48
HPGD P15428 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
TSHR P16473 2/20 0.48
CASP1 P29466 2/20 0.48
MAPK1 P28482 1/20 0.48
CASP7 P55210 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
PRNP P04156 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28426415 0.85 KDM4E (0.72) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL31723123 0.85 MAPT (0.67) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL20919340 0.85 MAPT (0.67) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL20923496 0.83 KMT2A (0.68) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL31723118 0.83 KMT2A (0.68) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL20919349 0.82 KDM4E (0.51) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL31723155 0.82 KDM4E (0.51) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL28431136 0.78 KDM4E (0.58) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL28429289 0.78 KDM4E (0.54) KMT2AMEN1KDM4EMAPTSMN1; SMN2
SCHEMBL28450669 0.78 KMT2A (0.51) KMT2AMEN1KDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed